Hospital del Mar Research Institute Hospital del Mar Research Institute

Clínica aplicada en neoplàsies hematològiques Beatriz Bellosillo

Cercador de publicacions

Publicacions 2024 (21)

  • Jain T*, Estrada-merly N, Queralt-Salas M, Kim S, Devos JD, Chen M, Fang X, Kumar R, Andrade-Campos M, Elmariah H, Agrawal V, Aljurf M, Bacher U, Badar T, Badawy SM, Ballen KK, Beitinjaneh A, Bhatt VR, Bredeson CN, Defilipp Z, Dholaria B, Farhadfar N, Farhan S, Gandhi A, Ganguly S, Gergis U, Grunwald MR, Hamad N, Hamilton BK, Inamoto Y, Iqbal M, Jamy O, Juckett M, Kharfan-dabaja MA, Krem MM, Lad DP, Liesveld JL, Al Malki, Malone AK, Murthy HS, Ortí G, Patel SS, Pawarode A, Perales MA, Van der, Ringden O, Rizzieri DA, Rovo A, Savani BN, Savoie ML, Seo S, Solh MM, Ustun C, Verdonck LF, Wingard JR, Wirk B, Bejanyan N, Jones RJ, Nishihori T, Oran B, Nakamura R, Scott BL, Saber W, Gupta V. Donor Types and Outcomes of Transplantation in Myelofibrosis: A CIBMTR Study. Blood Adv 2024: (en Premsa).
  • Montoro MJ*, Palomo L, Haferlach C, Acha P, Chan O, Navarro V, Kubota Y, Schulz FI, Meggendorfer M, Briski R, Al-ali N, Xicoy B, López F, Bosch F, González T, Eder LN, Jerez A, Wang YH, Campagna A, Santini V, Bernal-del Castillo T, Such E, Tien HF, Díaz-Varela N, Platzbecker U, Haase DT, Diez-Campelo M, Della Porta MG, García-Manero G, Wiseman DH, Germing U, Maciejewski JP, Komrokji RS, Sole F, Haferlach T, Valcárcel D. Influence of TP53 Gene Mutations and its Allelic Status in Myelodysplastic Syndromes with Isolated 5q Deletion. Blood 2024: (en Premsa).
  • Pastor-Galán I, Pereira A, Arellano-Rodrigo E*, Martin I, Mosquera-Orgueira A, Gómez-Casares MT, Hernández-Sánchez A, Ferrer-Marín F, Mora E, Vélez P, Ayala R, Angona A, De Las Heras N, Magro E, Mata-Vazquez MI, Fox ML, De Villambrosía S, Ramírez MJ, García A, García-Gutiérrez V, Cáceres A, Durán MA, Senín MA, Raya JM, González JA, Cuevas B, Xicoy B, Garrote M, Ferrer B, Pérez-Encinas M, Hernández-Rivas JM, Bellosillo B, Álvarez-Larran A, Hernández-Boluda JC*. Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis. Leukemia 2024: (en Premsa).
  • Chatzikonstantinou T, Scarfò L, Minga E, Karakatsoulis G, Chamou D, Kotaskova J, Iacoboni G, Demosthenous C, Albi E, Alcoceba M, Al-Shemari S, Aurran-Schleinitz T, Bacchiarri F, Chatzileontiadou S, Collado R, Davis Z, de Deus MD, Dimou M, Dmitrieva E, Donaldson D, Dos Santos G, Dreta B, Efstathopoulou M, El-Ashwah S, Enrico A, Frygier A, Galimberti S, Galitzia A, Gimeno E, Guarente V, Guieze R, Harrop S, Hatzimichael E, Herishanu Y, Hernández-Rivas JA, Jaksic O, Kalicinska E, Laribi K, Karakus V, Kater AP, Kho B, Kislova M, Konstantinou E, Koren-Michowitz M, Kotsianidis I, Kubova Z, Labrador J, Lad D, Laurenti L, Longval T, Lopez-Garcia A, Marquet J, Maslejova S, Mayor-Bastida C, Mihaljevic B, Milosevic I, Miras F, Moia R, Morawska M, Nath UK, Navarro-Bailón A, Olivieri J, Panovska-Stavridis I, Papaioannou M, Pierie C, Puiggros A, Reda G, Rigolin GM, Ruchlemer R, Schipani M, Schiwitza A, Shen Y, Shokralla T, Simkovic M, Smirnova S, Soliman DSA, Stilgenbauer S, Tadmor T, Tomic K, Tse E, Vassilakopoulos T, Visentin A, Vitale C, Vrachiolias G, Vukovic V, Walewska R, Xu Z, Yagci M, Yáñez L, Yassin M, Zuchnicka J, Oscier D, Gozzetti A, Panagiotidis P, Bosch F, Sportoletti P, Espinet B, Pangalis GA, Popov VM, Mulligan S, Angelopoulou M, Demirkan F, Papajík T, Biderman B, Murru R, Coscia M, Tam C, Cuneo A, Gaidano G, Claus R, Stavroyianni N, Trentin L, Antic D, Smolej L, Kalashnikova OB, Catherwood M, Spacek M, Pospisilova S, Doubek M, Nikitin E, Chatzidimitriou A, Ghia P*, Stamatopoulos K. Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL. Hemasphere . 2024; 8(9): e70004 (Acceptat).
  • Dal Cero M, Gibert J, Grande L, Gimeno M, Osorio J, Bencivenga M, Fumagalli Romario U, Rosati R, Morgagni P, Gisbertz S, Polkowski WP, Lara Santos L, Kolodziejczyk P, Kielan W, Reddavid R, Van Sandick J, Baiocchi GL, Gockel I, Davies A, Wijnhoven BPL, Reim D, Costa P, Allum WH, Piessen G, Reynolds JV, Mönig SP, Schneider PM, Garsot E, Eizaguirre E, Miró M, Castro S, Miranda C, Monzonis X, Pera MR*, On Behalf Of The Spanish Eurecca Esophagogastric Cancer Group And The European Gastrodata Study Group. International External Validation of Risk Prediction Model of 90-Day Mortality after Gastrectomy for Cancer Using Machine Learning. Cancers 2024; 16(13): 2463.
  • Salamero O*, Molero A, Pérez-Simón JA, Arnan M, Coll R, Garcia-Avila S, Acuña-Cruz E, Cano I, Somervaille TCP, Gutierrez S, Arévalo MI, Xaus J, Buesa C, Limón A, Faller DV, Bosch F, Montesinos P. Iadademstat in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (ALICE): an open-label, phase 2a dose-finding study. Lancet Haematology 2024; 11(7): e487-e498.
  • Papaleo NF, Molina-Alvarez A, Onieva R, Fuertes D, Sánchez-González B, Riera X, Lopez-Segura D, Lome-Maldonado C, Ara-Mancebo X, Yelamos J, Salido M, Vazquez I, Calvo X, Colomo L*. Chromogenic LMO2 mRNA ISH Expression Correlates with LMO2 Protein and Gene Expression and Captures Their Survival Impact in Diffuse Large B-Cell Lymphoma, NOS. Cancers 2024; 16(13): 2378.
  • Bessa X*, Vidal J, Balboa JC, Márquez C, Duenwald S, He Y, Raymond V, Faull I, Burón A, Álvarez C, Castells X, Bellosillo B, Montagut C*. High accuracy of a blood ctDNA-based multimodal test to detect colorectal cancer. Ann Oncol 2024; 34(12): 1187-1193.
  • Cornudella-Lema J, Sánchez-González B, Carrión-Barberá I*, Vázquez-Montes de Oca S, Garcia-Pallarols F, Salman-Monte TC. Immune thrombocytopenia in systemic lupus erythematosus: Prevalence, risk factors, and a novel predictive model for risk assessment. Med Clin (Barc) 2024; 162(10): 461-469.
  • Hontecillas-Prieto L, Garcia-Dominguez DJ, Palazón-Carrión N, Martin-Garcia-Sancho A, Nogales-Fernandez E, Jiménez-Cortegana C, Sánchez-León ML, Silva-Romeiro S, Flores-Campos R, Carnicero-González F, Ríos-Herranz E, de la Cruz F, Rodríguez-García G, Fernández-Alvarez R, Martínez-Banaclocha N, Gumà-Padrò J, Gómez-Codina J, Salar A, Rodríguez-Abreu D, Galvez-Carvajal L, Labrador J, Guirado-Risueño M, Provencio-Pulla M, Sánchez Beato M, Marylene L, Alvaro-Naranjo T, Casanova-Espinosa M, Rueda-Domínguez A, Sánchez-Margalet V*, de la Cruz-Merino L*. CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma. Front Immunol 2024; 15: 1293931 (Acceptat).
  • Fernández-Ibarrondo L. Dinámica clonal en las neoplasias mieloproliferativas crónicas. Universitat Pompeu Fabra. Director: Bellosillo B, Besses C. Fecha lectura: 05/04/2024.
    Cites:0
  • Bellosillo B, Ibáñez R, Roura E, Monfil L, Asensio-Puig L, Alvarez I, Muset M, Florencia Y, Paytubi S, de Andrés-Pablo A, Calvo S, Serrano L, Pavón MÁ, Lloveras B*. Clinical Validation of the Vitro HPV Screening Assay for Its Use in Primary Cervical Cancer Screening. Cancers 2024; 16(7): 1322.
  • Bastos-Oreiro M*, Gutiérrez A, Cabero A, López J, Villafuerte P, Jiménez-Ubieto A, De Oña R, de la Fuente A, Navarro B, Peñalver J, Martínez P, Alonso C, Infante M, Córdoba R, Perez-Montero B, Pérez de OteIza J, González-de-Villambrosio S, Fernández-Caldas P, Del Campo R, García-Belmonte D, Diaz-Gálvez J, Salar A, Sancho JM. Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study. Cancers 2024; 16(7): 1285.
  • Solé L, Lobo T, Cabré J, Gonzalez A, Fernández-Ibarrondo L, Marruecos L, Guix M, Cuatrecasas M, Lopez S, Bellosillo B, Torres F, Iglesias M, Bigas A, Espinosa L*. Loss of the epithelial marker CDX1 predicts poor prognosis in early-stage CRC patients. BBA-Mol Cell Res 2024; 1871(3): 119658.
  • Garrote M*, López-Guerra M, García-Pagán JC, Arellano-Rodrigo E, Ferrer-Marín F, Hernández-Boluda JC, Bellosillo B, Nomdedeu M, Hernández-Gea V, Triguero A, Guijarro F, Álamo J, Baiges A, Turon F, Colomer D, Cervantes F, Álvarez-Larran A. Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology. Ann Hematol 2024; 103(3): 737-747.
  • Torrens C*, Bellosillo B, Gibert J, Suarez-Lopez A, Santana F, Alier A. Are Cutibacterium acnes delivered from skin to deep tissues in primary reverse shoulder arthroplasty? A prospective study. Arch Orthop Traum Su 2024; 144(2): 635-640.
  • Blanco G, Lopez-Aventin D, Pujol RM, Gómez-Llonin A, Puiggros A, Lopez-Sanchez M, Estrach T, García-Muret MP, López-Lerma I, Servitje O, Bellosillo B, Muro M, Espinet B, Rabionet R, Gallardo F*. High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndrome. J Clin Lab Anal 2024; 37(23-24): e24982.
  • Chatzikonstantinou T, Scarfò L, Karakatsoulis G, Minga E, Chamou D, Iacoboni G, Kotaskova J, Demosthenous C, Smolej L, Mulligan S, Alcoceba M, Al-Shemari S, Aurran-Schleinitz T, Bacchiarri F, Bellido M, Bijou F, Calleja A, Medina A, Khan MA, Cassin R, Chatzileontiadou S, Collado R, Christian A, Davis Z, Dimou M, Donaldson D, Santos GD, Dreta B, Efstathopoulou M, El-Ashwah S, Enrico A, Fresa A, Galimberti S, Galitzia A, García-Serra R, Gimeno E, González-Gascón-Y-Marin I, Gozzetti A, Guarente V, Guieze R, Gogia A, Gupta R, Harrop S, Hatzimichael E, Herishanu Y, Hernández-Rivas JÁ, Inchiappa L, Jaksic O, Janssen S, Kalicinska E, Kamel L, Karakus V, Kater AP, Kho B, Kislova M, Konstantinou E, Koren-Michowitz M, Kotsianidis I, Kreitman RJ, Labrador J, Lad D, Levin MD, Levy I, Longval T, Lopez-Garcia A, Marquet J, Martin-Rodríguez L, Maynadié M, Maslejova S, Mayor-Bastida C, Mihaljevic B, Milosevic I, Miras F, Moia R, Morawska M, Murru R, Nath UK, Navarro-Bailón A, Oliveira AC, Olivieri J, Oscier D, Panovska-Stavridis I, Papaioannou M, Papajik T, Kubova Z, Phumphukhieo P, Pierie C, Puiggros A, Rani L, Reda G, Rigolin GM, Ruchlemer R, de Deus MD, Schipani M, Schiwitza A, Shen Y, Simkovic M, Smirnova S, Abdelrahman Soliman, Spacek M, Tadmor T, Tomic K, Tse E, Vassilakopoulos T, Visentin A, Vitale C, von Tresckow J, Vrachiolias G, Vukovic V, Walewska R, Wasik-Szczepanek E, Xu Z, Yagci M, Yáñez L, Yassin M, Zuchnicka J, Angelopoulou M, Antic D, Biderman B, Catherwood M, Claus R, Coscia M, Cuneo A, Demirkan F, Espinet B, Gaidano G, Kalashnikova OB, Laurenti L, Nikitin E, Pangalis GA, Panagiotidis P, Popov VM, Pospisilova S, Sportoletti P, Stavroyianni N, Tam C, Trentin L, Chatzidimitriou A, Bosch F, Doubek M, Ghia P*, Stamatopoulos K. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY. EClinicalMedicine . 2024; 65: 102307 (Acceptat).
  • Visentin A, Chatzikonstantinou T, Scarfò L, Kapetanakis A, Demosthenous C, Karakatsoulis G, Minga E, Chamou D, Allsup D, Cabrero AA, Andres M, Antic D, Baile M, Baliakas P, Besikli-Dimou S, Bron D, Chatzileontiadou S, Cordoba R, Correa JG, Cuéllar-García C, de Paoli L, de Paolis MR, Delgado J, Dimou M, Donaldson D, Catherwood M, Doubek M, Efstathopoulou M, Eichhorst B, Elashwah S, Enrico A, Espinet B, Farina L, Ferrari A, Foglietta M, Frederiksen H, Fürstenau M, García-Marco JA, García-Serra R, Collado R, Gentile M, Gimeno E, Glenthøj A, DA Silva, Hakobyan YK, Herishanu Y, Hernández-Rivas JÁ, Herold T, Innocenti I, Itchaki G, Jaksic O, Janssens A, Kalashnikova OB, Kalicinska E, Kater AP, Kersting S, Labrador J, Lad D, Laurenti L, Levin MD, Lista E, Lopez-Garcia A, Malerba L, Marasca R, Marchetti M, Marquet J, Mattsson M, Mauro FR, Morawska M, Motta M, Munir T, Murru R, Niemann CU, Rodrigues RN, Olivieri J, Orsucci L, Papaioannou M, Pavlovsky MA, Piskunova I, Popov VM, Quaglia FM, Quaresmini G, Qvist K, Rigolin GM, Ruchlemer R, Simkovic M, Spacek M, Sportoletti P, Stanca O, Tadmor T, Capasso A, del Poeta G, Gutwein O, Karlsson LK, Milosevic I, Mirás F, Reda G, Saghumyan G, Shrestha A, TE Raa, Tonino SH, van der Spek E, van Gelder M, van Kampen R, Wasik-Szczepanek E, Wróbel T, Yuñez-San Segundo L, Yassin M, Pocali B, Vandenberghe E, Iyengar S, Varettoni M, Vitale C, Coscia M, Rambaldi A, Montserrat E, Cuneo A, Stavroyianni N, Trentin L, Stamatopoulos K*, Ghia P*. The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL. Am J Hematol 2024; 98(12): 1856-1868.
  • Hernández-Sánchez A*, Villaverde-Ramiro Á, Arellano-Rodrigo E, Garrote M, Martin I, Mosquera-Orgueira A, Gómez-Casares MT, Ferrer-Marín F, Such E, Velez P, Ayala R, Angona A, De Las Heras N, Magro E, Mata-Vazquez MI, Fox ML, De Villambrosía S, Ramirez MJ, García A, García-Gutiérrez V, Cáceres A, Durán MA, Senín A, Raya JM, González JM, Cuevas B, Xicoy B, Pérez-Encinas M, Bellosillo B, Álvarez-Larrán A, Hernández-Rivas JM*, Hernández-Boluda JC*, Spanish MPN Group (GEMFIN). The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis. Am J Hematol 2024; 99: 755-758.
  • Diez-Feijoo R, Andrade-Campos M, Gibert J, Sánchez-González B, Fernández-Ibarrondo L, Fernández-Rodríguez MC, Garcia N, Camacho L, Lafuente M, Vazquez I, Colomo L, Salar A*, Bellosillo B. Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas. Cancers 2024; 16(2): 321.

Contacte

Coordinadora:
Beatriz Bellosillo(ELIMINAR)

Tel:
93 248 35 61

Pg. Marítim 25-29
08003 Barcelona

© Institut Hospital del Mar
d'Investigacions Mèdiques
Avís Legal i Política de Privacitat | Política de cookies | Mapa web | Accessibilitat | Adreça / Accessos | Contacte